However, some investigations, particularly in later pregnancy, have found lower visfatin levels in women with GDM compared to normoglycemic controls, and visfatin levels have been inversely correlated with insulin resistance markers such as homeostatic model assessment of insulin resistance (HOMA-IR) in healthy pregnancies but not consistently in GDM. The gene discussed is NAMPT; the disease is Insulin resistance.